Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Wegovy pill · purple gradient. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The empty frame is the point: one small white pill sitting alone in a field of purple makes the product feel new and simple, and it contrasts with the pens most GLP-1 ads show. Ro pairs that with a headline that names the product plainly (The new Wegovy pill) and a second line that gives a reason to care, with the word affordable picked out in yellow. The When paying cash note sits right under the claim, so the price promise comes with its condition attached.
The ad relies on the viewer already knowing what Wegovy is and why a pill version matters. There's no line about who it's for, what changes when you switch from a shot, or how much it costs, so most affordable has nothing to measure against. If you use this kind of quiet launch image, add the actual starting price or one sentence on why the new format matters, so the minimal design carries a specific message.
It announces the product by name, which works for people who already know the brand.
It gives the reason to click and states the condition right next to the claim.
The negative space makes the pill feel new and easy, in contrast to injection pens.
No price is shown; the ad claims the Wegovy pill is the most affordable cash-pay GLP-1 on Ro when paying cash.
The ad lands on Ro's quiz entry, which is a better destination than a homepage because the first question (Which Ro option are you interested in?) lists GLP-1 pill as its top choice. That's a clean continuation for someone who clicked on a pill ad. The page doesn't name the Wegovy pill or show any price, so the affordability claim that earned the click isn't repeated on arrival. Naming the Wegovy pill under the pill option would make the match exact.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.